Evidence map›Paper›PMID 30580047›Full record

Observational studyThe journal of allergy and clinical immunology. In practice

Sinus Surgery Is Associated with a Decrease in Aspirin-Induced Reaction Severity in Patients with Aspirin Exacerbated Respiratory Disease.

Elina Jerschow, Matthew L Edin, Yuling Chi, Beth Hurst, Waleed M Abuzeid, Nadeem A Akbar, Marc Gibber, Marvin P Fried, Weiguo Han, Teresa Pelletier and 10 more

Registry-linked trialOpen access · greenAbstract readObservational Study
In one paragraph

Observational study in The journal of allergy and clinical immunology. In practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05246267 (Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05246267 recruitingnot on this map

Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)

TypeobservationalSponsorMontefiore Medical CenterRan2022 to 2026Enrolled60ConditionsChronic Rhinosinusitis With Nasal PolypsArmsDupilumab
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Urinary Leukotriene EAllergy · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Updates on the Natural History and Clinical Characteristics of NSAID-ERD.The journal of allergy and clinical immunology. In practice · 2024
    Review
  10. [Expert consensus on the diagnosis and treatment of respiratory diseases exacerbated by nonsteroidal anti-inflammatory drugs (2024, Chengdu)].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Article
  11. Article
  12. Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease?The journal of allergy and clinical immunology. In practice · 2024
    Review
  13. Review
  14. Aspirin-exacerbated respiratory disease: Updates in the era of biologics.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2023
    Review
  15. Article
  16. Mechanistic and clinical updates in AERD: 2021-2022.The Journal of allergy and clinical immunology · 2023
    Article
  17. During aspirin desensitization, omitting repeated provoking aspirin dose is safe.The journal of allergy and clinical immunology. In practice · 2023
    Article
  18. Review
  19. The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Elina JerschowAlbert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY. Electronic address: Elina.Jerschow@einstein.yu.edu.
Matthew L EdinNational Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle, NC.
Yuling ChiAlbert Einstein College of Medicine, Bronx, NY.
Beth HurstCayman Chemical Inc., Ann Arbor, Mich.
Waleed M AbuzeidAlbert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Nadeem A AkbarAlbert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Marc GibberAlbert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Marvin P FriedAlbert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Weiguo HanAlbert Einstein College of Medicine, Bronx, NY.
Teresa PelletierAlbert Einstein College of Medicine, Bronx, NY.
Zhen RenWashington University School of Medicine, St. Louis, Mo.
Taha KeskinAlbert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Gigia RoizenAlbert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Fred B LihNational Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle, NC.
Artiom GruzdevNational Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle, NC.
J Alyce BradburyNational Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle, NC.
Victor SchusterAlbert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Simon SpivackAlbert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
David RosenstreichAlbert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Darryl C ZeldinNational Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle, NC.
Albert Einstein College of Medicine · USNational Institute of Environmental Health Sciences · USMontefiore Medical Center · USCayman Chemical (United States) · USNational Institutes of Health · USWashington University in St. Louis · US

Funding

CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patientsUL1TR002556 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, KIM, MIMI Y · 2018 to 2022
$26.7M
NIEHS Knock Out Mouse Core (KOMC) Annual ReportZICES102425 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RAY, MANAS · 2010 to 2025
$20.1M
P450 Arachidonate EpoxygenasesZ01ES025034 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ZELDIN, DARRYL C · 1995 to 2008
$2.2M
Clinical and Translational Science AwardKL2TR001071 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHAMOON, HARRY · 2013 to 2017
$968k
Intramural NIH HHS Z01 ES025034NCATS NIH HHS KL2 TR001071NCATS NIH HHS UL1 TR002556
6 · The paper itself

Abstract

backgroundNasal polyps influence the burden of aspirin-exacerbated respiratory disease (AERD) by contributing to eicosanoid production. AERD is diagnosed through graded aspirin challenges. It is not known how sinus surgery affects aspirin challenge outcomes.

objectiveTo investigate the effects of endoscopic sinus surgery (ESS) on aspirin-induced reaction severity and on the levels of eicosanoids associated with these reactions.

methodsTwenty-eight patients with AERD were challenged with aspirin before and 3 to 4 weeks after ESS. Respiratory parameters and plasma and urine levels of eicosanoids were compared before and after challenges.

resultsBefore ESS, AERD diagnosis was confirmed in all study patients by aspirin challenges that resulted in hypersensitivity reactions. After ESS, reactions to aspirin were less severe in all patients and 12 of 28 patients (43%, P < .001) had no detectable reaction. A lack of clinical reaction to aspirin was associated with lower peripheral blood eosinophilia (0.1 K/μL [interquartile range (IQR) 0.1-0.3] vs 0.4 K/μL [IQR 0.2-0.8]; P = .006), lower urinary leukotriene E

conclusionsSinus surgery results in decreased aspirin sensitivity and a decrease in several plasma and urine eicosanoid levels in patients with AERD. Diagnostic aspirin challenges should be offered to patients with suspected AERD before ESS to increase diagnostic accuracy. Patients with established AERD could undergo aspirin desensitizations after ESS as the severity of their aspirin-induced hypersensitivity reactions lessens.

Indexed as

Asthma, Aspirin-InducedEndoscopyNasal Surgical ProceduresAdultAspirinEicosanoidsFemaleForced Expiratory VolumeHumansMaleMiddle AgedNitric OxideParanasal SinusesSeverity of Illness IndexAspirinEicosanoidsNitric OxideAspirin challengesAspirin-exacerbated respiratory diseaseEicosanoidsEndoscopic sinus surgeryEosinophilsNasal polyps

Identifiers

PMID30580047
PMCPMC6511299
OpenAlexW2904920064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.